| Galilee Energy Limited (GLL) ORDINARY FULLY PAID |
Energy |
$8 |
Application for quotation of securities - GLL
|
16 May 2025 10:08AM |
$0.006 |
$0.009 |
risen by
50%
|
|
| Empire Energy Group Limited (EEG) ORDINARY FULLY PAID |
Energy |
$228 |
Empire Energy completes $28M placement and launches SPP
|
16 May 2025 9:59AM |
$0.205 |
$0.185 |
fallen by
9.76%
|
|
EEG - Price-sensitive ASX Announcement
Full Release
Key Points
- Empire Energy Group Limited completed a $28 million institutional placement.
- A Share Purchase Plan (SPP) to raise up to $5 million was launched.
- Funds will be used to advance the Carpentaria Pilot Project in the Beetaloo Sub-basin, NT.
- Primary focus is on early-stage commercial hydrocarbon production and appraisal.
- Placement was managed by Macquarie Capital and Euroz Hartleys.
- Funds also earmarked for exploration and further development in the Beetaloo Sub-basin.
- Strong investor support was noted in the placement.
- Company aims to fast-track project development and maximize shareholder value.
- Announcement outlines structure and rationale for the capital raising.
- Reaffirms strategy toward commercial gas production in Northern Territory.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Recce Pharmaceuticals Ltd (RCE) ORDINARY FULLY PAID |
Health Care |
$188 |
Results of Entitlement Offer
|
16 May 2025 9:58AM |
$0.295 |
$0.650 |
risen by
120.34%
|
|
| Lucapa Diamond Company Limited (LOM) ORDINARY FULLY PAID |
Materials |
- |
Suspension from Quotation
|
16 May 2025 9:57AM |
$0.014 |
$0.014 |
fallen by
0%
|
|
| Lion Selection Group Limited (LSX) ORDINARY FULLY PAID |
Financials |
$148 |
Lion invests $2.0M in Medallion Metals
|
16 May 2025 9:53AM |
$0.675 |
$1.035 |
risen by
53.33%
|
|
| ECS Botanics Holdings Ltd (ECS) ORDINARY FULLY PAID |
Health Care |
$11 |
Record Harvest and Expansion of Premium B2C Product Line
|
16 May 2025 9:53AM |
$0.009 |
$0.007 |
fallen by
22.22%
|
|
ECS - Price-sensitive ASX Announcement
Full Release
Key Points
- ECS Botanics Holdings Ltd reported a record harvest.
- The company has expanded its premium B2C (business-to-consumer) product line.
- Increased harvest yields are expected to support ongoing and future product development.
- ECS continues to focus on sustainable, high-quality cannabis cultivation.
- Expansion of premium product offerings aims to boost market share and brand reputation.
- Company maintains its commitment to operational excellence and customer satisfaction.
- Harvest results are intended to be leveraged for future business growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Midas Minerals Ltd (MM1) ORDINARY FULLY PAID |
Materials |
$164 |
Otavi Project Investor Presentation
|
16 May 2025 9:52AM |
$0.158 |
$0.805 |
risen by
411.11%
|
|
MM1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Midas Minerals Ltd (MM1) is focused on exploration and development of battery and technology metals.
- The Otavi Project in Namibia targets lithium, rare earth elements, and copper mineralization.
- Namibia is highlighted as a stable, mining-friendly jurisdiction with existing infrastructure.
- The Otavi region is underexplored but geologically prospective for lithium and REEs.
- Previous exploration identified lithium and REE mineralization at shallow depths.
- MM1's 2024 work program includes drilling, mapping, soil and rock sampling, and geophysical surveys.
- Global demand for lithium and REEs is rising due to the shift to clean energy technologies.
- MM1's leadership team has significant experience in mineral exploration and project development.
- The company aims to rapidly advance exploration to resource definition and development stages.
- MM1 presents a strong investment case based on project prospectivity, jurisdiction, and market trends.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bryah Resources Limited (BYH) ORDINARY FULLY PAID |
Materials |
$6 |
Trading Halt
|
16 May 2025 9:50AM |
$0.004 |
$0.004 |
fallen by
0%
|
|
BYH - Price-sensitive ASX Announcement
Full Release
Key Points
- Bryah Resources Limited requested a trading halt on 8 March 2023.
- The trading halt is pending the release of a material capital raising announcement.
- The halt is to remain until the earlier of an announcement or the start of trading on 10 March 2023.
- Ashley Jones, acting CEO, authorized the request.
- The trading halt aims to ensure an orderly market during the announcement of sensitive information.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Recce Pharmaceuticals Ltd (RCE) ORDINARY FULLY PAID |
Health Care |
$188 |
Application for quotation of securities - RCE
|
16 May 2025 9:50AM |
$0.295 |
$0.650 |
risen by
120.34%
|
|
| SHAPE Australia Corporation Limited (SHA) ORDINARY FULLY PAID |
Industrials |
$552 |
Change in substantial holding
|
16 May 2025 9:50AM |
$3.220 |
$6.610 |
risen by
105.28%
|
|
| Latitude 66 Limited (LAT) ORDINARY FULLY PAID |
Materials |
$20 |
KSB Project Permit Update
|
16 May 2025 9:49AM |
$0.045 |
$0.135 |
risen by
200%
|
|
LAT - Price-sensitive ASX Announcement
Full Release
Key Points
- Latitude 66 Limited (LAT) is progressing with environmental permitting for the KSB Project in Finland.
- The company is engaging closely with Finnish regulatory authorities on permitting processes.
- LAT has submitted required documentation and continues to participate in discussions with authorities.
- The project is guided by a commitment to environmental compliance, responsible development, and transparency.
- LAT is focused on maintaining open communication with stakeholders and the local community.
- Updates on permitting milestones and future steps will be communicated as the project advances.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Southern Cross Media Group Limited (SXL) ORDINARY FULLY PAID |
Communication Services |
$330 |
TOV: SXL - Panel Receives Request for Variation of Orders
|
16 May 2025 9:48AM |
$0.750 |
$0.690 |
fallen by
8%
|
|
| Fat Prophets Global Contrarian Fund Limited (FPC) ORDINARY FULLY PAID |
Financials |
$44 |
Weekly NAV
|
16 May 2025 9:44AM |
$0.970 |
$1.570 |
risen by
61.86%
|
|
| Legacy Minerals Holdings Limited (LGM) ORDINARY FULLY PAID |
Materials |
$41 |
Retraction Announcement 13 May 2025
|
16 May 2025 9:43AM |
$0.215 |
$0.233 |
risen by
8.14%
|
|
| Midas Minerals Ltd (MM1) ORDINARY FULLY PAID |
Materials |
$164 |
Proposed issue of securities - MM1
|
16 May 2025 9:43AM |
$0.158 |
$0.805 |
risen by
411.11%
|
|
| Midas Minerals Ltd (MM1) ORDINARY FULLY PAID |
Materials |
$164 |
Transformational Project Acquisition
|
16 May 2025 9:43AM |
$0.158 |
$0.805 |
risen by
411.11%
|
|
MM1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Midas Minerals Ltd announced acquisition of the MM1 Project in Minas Gerais, Brazil.
- Project is a large-scale lithium-caesium-tantalum (LCT) pegmatite target covering 144km².
- Located in a prolific lithium-bearing region with established infrastructure and mining activity.
- Outcropping pegmatites observed with visible spodumene, indicating high lithium potential.
- Deal structure includes upfront and milestone-based payments.
- Midas to commence on-ground exploration, including drilling, immediately.
- Acquisition aligns with strategic expansion into the lithium sector and diversification of assets.
- MM1 Project complements Midas’s Australian projects and supports rapid sector entry.
- Brazil is emerging as a major global lithium producer with favorable mining conditions.
- Acquisition described as transformational for Midas’s growth and strategic objectives.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ABx Group Limited (ABX) ORDINARY FULLY PAID |
Materials |
$30 |
Amendment to ASX Announcement
|
16 May 2025 9:41AM |
$0.044 |
$0.084 |
risen by
90.91%
|
|
| Nine Entertainment Co. Holdings Limited (NEC) ORDINARY FULLY PAID |
Communication Services |
$1,792 |
Disclosure of Equity Swap Transactions
|
16 May 2025 9:40AM |
$1.525 |
$1.130 |
fallen by
25.90%
|
|
| Aurumin Limited (AUN) ORDINARY FULLY PAID |
Materials |
$54 |
Suspension from Quotation
|
16 May 2025 9:38AM |
$0.078 |
$0.105 |
risen by
34.62%
|
|
AUN - Price-sensitive ASX Announcement
Full Release
Key Points
- Aurumin Limited (AUN) has requested a voluntary suspension from quotation on the ASX.
- The suspension is effective from 21 June 2023.
- The suspension is pending an announcement regarding a proposed capital raising.
- The company aims to ensure the market is fully informed before resuming trading.
- The suspension will remain in place until the announcement is released or normal trading resumes on 23 June 2023.
- This request follows a previous trading halt.
- Aurumin Limited is not aware of any reason why the voluntary suspension should not be granted.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| HitIQ Limited (HIQ) ORDINARY FULLY PAID |
Health Care |
$9 |
Entitlement Offer - Option Holders Letter
|
16 May 2025 9:37AM |
$0.021 |
$0.017 |
fallen by
17.07%
|
|
| Anatara Lifesciences Ltd (ANR) ORDINARY FULLY PAID |
Health Care |
$4 |
Phase II GaRP-IBS Trial Internal Analyses of Data Subsets
|
16 May 2025 9:37AM |
$0.006 |
$0.014 |
risen by
133.33%
|
|
ANR - Price-sensitive ASX Announcement
Full Release
Key Points
- Anatara Lifesciences completed internal analyses of patient data subsets from its Phase II GaRP-IBS clinical trial.
- The main trial did not meet the primary endpoint in the overall study population.
- Exploratory analyses identified that subgroups such as IBS-D patients, males, and younger participants exhibited clinically meaningful improvements.
- The analyses focused on measures like abdominal pain reduction and bowel habit normalization.
- The results will inform future clinical development, including the design of targeted Phase II trials.
- Anatara is engaging with potential partners and regulatory agencies based on these findings.
- The GaRP supplement is being further evaluated for its potential benefits in selected IBS patient subgroups.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Etherstack PLC (ESK) CHESS DEPOSITARY INTERESTS 1:1 |
Information Technology |
$79 |
Trading Update Record H1 Cash Receipts
|
16 May 2025 9:35AM |
$0.290 |
$0.560 |
risen by
93.10%
|
|
ESK - Price-sensitive ASX Announcement
Full Release
Key Points
- Etherstack PLC reported unaudited cash receipts of approximately US$4.2 million for H2 2023.
- This represents a 17% increase over the prior corresponding period.
- The cash receipts for this December half-year are the highest on record for the company.
- Growth driven by strong client demand and both new and repeat project contracts.
- Continued momentum and project execution success with existing and new customers.
- Etherstack maintains a healthy balance sheet with no debt.
- Financial strength supports ongoing investment in product development and client delivery.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Hillgrove Resources Limited (HGO) ORDINARY FULLY PAID |
Materials |
$167 |
Appointment of Chief Financial Officer
|
16 May 2025 9:34AM |
$0.036 |
$0.049 |
risen by
36.11%
|
|
| Forrestania Resources Limited (FRS) ORDINARY FULLY PAID |
Materials |
$356 |
Proposed issue of securities - FRS
|
16 May 2025 9:34AM |
$0.051 |
$0.495 |
risen by
870.59%
|
|
| Aspen Group (APZ) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$1,293 |
Successful Completion of Equity Raising
|
16 May 2025 9:33AM |
$3.000 |
$5.680 |
risen by
89.33%
|
|